Research article Special Issues

Virtual target screening to rapidly identify potential protein targets of natural products in drug discovery

  • Inherent biological viability and diversity of natural products make them a potentially rich source for new therapeutics. However, identification of bioactive compounds with desired therapeutic effects and identification of their protein targets is a laborious, expensive process. Extracts from organism samples may show desired activity in phenotypic assays but specific bioactive compounds must be isolated through further separation methods and protein targets must be identified by more specific phenotypic and in vitro experimental assays. Still, questions remain as to whether all relevant protein targets for a compound have been identified. The desire is to understand breadth of purposing for the compound to maximize its use and intellectual property, and to avoid further development of compounds with insurmountable adverse effects. Previously we developed a Virtual Target Screening system that computationally screens one or more compounds against a collection of virtual protein structures. By scoring each compound-protein interaction, we can compare against averaged scores of synthetic drug-like compounds to determine if a particular protein would be a potential target of a compound of interest. Here we provide examples of natural products screened through our system as we assess advantages and shortcomings of our current system in regards to natural product drug discovery.

    Citation: Yuri Pevzner, Daniel N. Santiago, Jacqueline L. von Salm, Rainer S. Metcalf, Kenyon G. Daniel, Laurent Calcul, H. Lee Woodcock, Bill J. Baker, Wayne C. Guida, Wesley H. Brooks. Virtual target screening to rapidly identify potential protein targets of natural products in drug discovery[J]. AIMS Molecular Science, 2014, 1(2): 81-98. doi: 10.3934/molsci.2014.2.81

    Related Papers:

    [1] Benjamin H. Singer, Denise E. Kirschner . Influence of backward bifurcation on interpretation of $R_0$ in a model of epidemic tuberculosis with reinfection. Mathematical Biosciences and Engineering, 2004, 1(1): 81-93. doi: 10.3934/mbe.2004.1.81
    [2] Kento Okuwa, Hisashi Inaba, Toshikazu Kuniya . An age-structured epidemic model with boosting and waning of immune status. Mathematical Biosciences and Engineering, 2021, 18(5): 5707-5736. doi: 10.3934/mbe.2021289
    [3] Zhiping Liu, Zhen Jin, Junyuan Yang, Juan Zhang . The backward bifurcation of an age-structured cholera transmission model with saturation incidence. Mathematical Biosciences and Engineering, 2022, 19(12): 12427-12447. doi: 10.3934/mbe.2022580
    [4] Aili Wang, Yanni Xiao, Huaiping Zhu . Dynamics of a Filippov epidemic model with limited hospital beds. Mathematical Biosciences and Engineering, 2018, 15(3): 739-764. doi: 10.3934/mbe.2018033
    [5] Liumei Wu, Baojun Song, Wen Du, Jie Lou . Mathematical modelling and control of echinococcus in Qinghai province, China. Mathematical Biosciences and Engineering, 2013, 10(2): 425-444. doi: 10.3934/mbe.2013.10.425
    [6] Elamin H. Elbasha . Model for hepatitis C virus transmissions. Mathematical Biosciences and Engineering, 2013, 10(4): 1045-1065. doi: 10.3934/mbe.2013.10.1045
    [7] Yuyi Xue, Yanni Xiao . Analysis of a multiscale HIV-1 model coupling within-host viral dynamics and between-host transmission dynamics. Mathematical Biosciences and Engineering, 2020, 17(6): 6720-6736. doi: 10.3934/mbe.2020350
    [8] Muntaser Safan, Bayan Humadi . An SIS sex-structured influenza A model with positive case fatality in an open population with varying size. Mathematical Biosciences and Engineering, 2024, 21(8): 6975-7011. doi: 10.3934/mbe.2024306
    [9] Kento Okuwa, Hisashi Inaba, Toshikazu Kuniya . Mathematical analysis for an age-structured SIRS epidemic model. Mathematical Biosciences and Engineering, 2019, 16(5): 6071-6102. doi: 10.3934/mbe.2019304
    [10] Lin Chen, Xiaotian Wu, Yancong Xu, Libin Rong . Modelling the dynamics of Trypanosoma rangeli and triatomine bug with logistic growth of vector and systemic transmission. Mathematical Biosciences and Engineering, 2022, 19(8): 8452-8478. doi: 10.3934/mbe.2022393
  • Inherent biological viability and diversity of natural products make them a potentially rich source for new therapeutics. However, identification of bioactive compounds with desired therapeutic effects and identification of their protein targets is a laborious, expensive process. Extracts from organism samples may show desired activity in phenotypic assays but specific bioactive compounds must be isolated through further separation methods and protein targets must be identified by more specific phenotypic and in vitro experimental assays. Still, questions remain as to whether all relevant protein targets for a compound have been identified. The desire is to understand breadth of purposing for the compound to maximize its use and intellectual property, and to avoid further development of compounds with insurmountable adverse effects. Previously we developed a Virtual Target Screening system that computationally screens one or more compounds against a collection of virtual protein structures. By scoring each compound-protein interaction, we can compare against averaged scores of synthetic drug-like compounds to determine if a particular protein would be a potential target of a compound of interest. Here we provide examples of natural products screened through our system as we assess advantages and shortcomings of our current system in regards to natural product drug discovery.


    Mathematical epidemiology constructs mathematical models to understand the dynamics of transmissible diseases, study disease control and elimination, compare strategies of treatments and vaccinations, predict the peak time of an epidemic, and estimate the final size of an outbreak. In the process, mathematical theories on transmission dynamics of infectious diseases are enriched.

    It was Kermack and McKendrick who established the celebrated threshold theory to prognosticate the occurrence of an epidemic [1,2]. Their threshold was given explicitly in terms of the initial size of the susceptible population (the size of the community). If the initial size of the susceptible population is less than the threshold value, no epidemic can occur; otherwise, it can occur. The use of mass-action law by Kermack and McKendrick was the fundamental for them to address the threshold in terms of the density of the susceptible. Adding vital dynamics from Kermack and McKendrick's epidemic models, Hethcote [3,4] showed that the threshold is a global critical value (regardless of the initial conditions) for S-I-S models and S-I-R models (even when vaccination was included). Lajmanovich and York [5] and Hethcote and van Ark [6] found that the global threshold is valid for multi-group S-I-S models for the spread of gonorrhea, but each group had constant sizes.

    Starting in the early 1980's, the threshold for epidemic models has been consistently denoted by $ {{{\cal R}_{0}}} $, which is now formally defined as the expected number of secondary cases produced by a typical infected individual during its entire infectious period in a susceptible population. Though it took many iterations to define $ {{{\cal R}_{0}}} $ [7], each step along the way to properly interpret this critical biological number is a prominent landmark in mathematical epidemiology. For instance, basic reproduction rate had been seen in [8,9,10]; infectious contact number and replacement number were seen in [3,4,11]; the basic reproduction rate later was replaced by basic reproduction ratio such as in [12,13]; and finally basic reproduction number has been uniformly accepted since the earlier 1990's [14].

    As a fundamental threshold, the basic reproduction number plays the foremost role in determining whether a disease can take off or not. If the basic reproduction number for a disease is greater than one, that disease can invade a population. If it's less than one, the disease dies out (for instance see [12,13]). The primary purpose of this paper, however, is to demonstrate that the beauty of $ {{{\cal R}_{0}}} $ is not the only story in mathematical epidemiology.

    In fact, many epidemiological models have questioned whether a single threshold could completely determine the dynamics of a disease. One has observed that multi-threshold values are necessary to completely determine the dynamics of the disease [15,16,17,18]. As a result, a collection of epidemic models have shown that bi-stability occurs when $ {{{\cal R}_{0}}} < 1 $, which typically has been driven by the occurrence of backward bifurcations [19,20,21,22].

    As is shown schematically in Figure 1, when the bifurcation at $ {{{\cal R}_{0}}} = 1 $ is forward, $ {{{\cal R}_{0}}} > 1 $ implies disease can invade population; while $ {{{\cal R}_{0}}} < 1 $, the disease cannot invade the population. If the bifurcation is backward at $ {{{\cal R}_{0}}} = 1 $, there exists a stable equilibrium (even a stable limit cycle exists) when $ {{{\cal R}_{0}}} < 1 $ [17], i.e., the disease does not die out even though $ {{{\cal R}_{0}}} < 1 $.

    Figure 1.  Left figure is a forward bifurcation diagram, right a backward bifurcation diagram.

    The study of backward bifurcations has a fairly long history. We briefly review the earlier research in mathematical epidemiology on backward bifurcations. Mathematical epidemiology literature first reported the multiple endemic equilibria in mathematical models for the spread of HIV in 1989 by Castillo-Chavez and collaborators [23]. It historically challenged that "thinking that S-I-R epidemic models do not have multiple endemic equilibria is not accurate". Their later papers further confirmed that multiple group model of S-I-R type can have multiple endemic equilibria due to the varying sub-population sizes [24]. By considering that the birth rate is affected by the disease, Diekmann and Kretzschmar observed multiple stable equilibria in 1991 [25]. However, neither [23] nor [25] explicitly used the words– backward bifurcation. It wasn't until 1995 that Hadeler and Castillo-Chavez first formally used the name: backward bifurcation, and its the occurrence was due to the introduction of core group and non-core group [26].

    Hadeler and van der Driessche's paper in 1997 entitled "Backward bifurcation in epidemic control" [22] studied groups of two that have different susceptibilities can lead to the bi-stability situation. Dushoff et al. explored possible mechanisms behind backward bifurcations in simple disease models in 1998 [27]. This research further developed a theoretical local bifurcation indicator that determines whether forward or backward from earlier work in [24]. Later, this indicator was well formulated in [18] and [21]. The new millennium saw an new exploration in the study of backward bifurcations. Variety of mechanisms behind backward bifurcations have been identified in epidemic models. Castillo-Chavez and Feng [15] constructed dynamic model for the transmission of tuberculosis, claiming that exogenous reinfections can result in backward bifurcations, which was later found in other mathematical models for the transmission of tuberculosis [28,29,30]. It was shown by Kribs-Zaleta and Velasco-Hernández in [31] and by Brauer in [19,20] that vaccinations can trigger backward bifurcation. Martcheva and Thieme showed that super-infections, a sort of reinfection, are one mechanism in generating backward bifurcations [32]. When looking back the mathematical models for tuberculosis [15,28,29,30] collectively, one can conclude that reinfection would naturally cause backward bifurcations. Wang [33] and our previous work [17] showed that non-standard treatment strategies can cause the occurrence of backward bifurcation. Here, we very briefly review some well-known studies for backward bifurcations in deterministic differential equation models for disease transmission. It is worth mentioning that backward bifurcations have been found in stochastic and discrete epidemic models (for instance, see [34,35]).

    The basic reproduction number was found in measuring the primary infection force. When reinfections take place, how do we measure the reinfection forces? Corresponding to $ {{{\cal R}_{0}}} $, this paper finds a basic reinfection number that measures the reinfection forces, which turns out to be a new tipping point for disease dynamics.

    The following Theorem 1 is a successful and convenient approach in determining whether or not a system exhibits a backward bifurcation ([18,21,27]). It will be repeatedly used in this article to guide all our calculations.

    Theorem 1. [21] Consider a system of ordinary differential equations

    $ dxdt=f(x,ϕ),f:Rn×RRn  and  fC2(Rn×R),
    $
    (1.1)

    with a parameter $ \phi $. Assume that:

    1. $ 0 $ is an equilibrium of the system, that is, $ f(0, \phi) \equiv 0 $ for all $ \phi $; and

    2. Zero is a simple eigenvalue of $ D_xf(0, 0) = \left(\frac{\partial f_i}{\partial x_j}(0, 0)\right) $ and all other eigenvalues of $ D_xf(0, 0) $ have negative real parts.

    Let $ \mathbf{W} = [w_1, w_2, \cdots, w_n]' $ and $ \mathbf{V} = [v_1, v_2, \cdots, v_n] $ be a right and a left eigenvector matrix $ D_xf(0, 0) $, respectively, corresponding to the zero eigenvalue; and let $ f_k(x, \phi) $ be the $ k $th component of $ f(x, \phi) $. Then the local dynamics of system $(1.1)$ around the equilibrium $ 0 $ is totally determined by the signs of $ a $ and $ b $ below:

    $ a=nk,i,j=1vkwiwj2fkxixj(0,0),
    $
    (1.2)
    $ b=nk,i=1vkwi2fkxiϕ(0,0).
    $
    (1.3)

    Particularly, if $ b > 0 $ and $ a > 0 $, then a backward bifurcation occurs for system $(1.1)$ at $ \phi = 0 $; while $ b > 0 $ and $ a < 0 $, a forward bifurcation occurs.

    When applying Theorem 1 to an epidemiological model, the equilibrium $ 0 $ corresponds to the disease-free equilibrium and $ \phi = {{{\cal R}_{0}}}-1 $. That is, $ \phi = 0 $ corresponds to $ {{{\cal R}_{0}}} = 1 $. Theorem 1 here is not exactly the same as Thorem 4.1 in [21], because we have dropped the assumption that $ \mathbf{W} $ is nonnegative (see Remark 1 in [21]).

    In this section, we use a simple epidemic model to introduce our essential concept: the basic reinfection number.

    We first introduce a mathematical model for a socially transmitted disease such as cigarettes smoking (or drug abuse), where peer pressure or peer influence presumably plays a critical role. The entire population is divided into nonsmokers, smokers, temporary quitters, and permanent quitters. Let $ S $ be the number of nonsmokers; $ I $ the number of smokers; $ R $ the number of the individuals who temporarily quit smoking but have not decided if quit smoking forever; and $ T $ the number of individuals who has commit to quitting cigarettes smoking permanently. A system of ordinary differential equations is used to model the dynamics of cigarettes smoking. The model equations read

    $ {dSdt=μNβ1SINμS,dIdt=β1SIN+β2RINμIαI,dRdt=αIβ2RINμRγR,dTdt=γRμT,N=S+I+R+T.
    $
    (2.1)

    The per-capita birth rate and the per-capita death rate are assumed to equal ($ \mu $). $ \beta_1 S \frac{I}{N} $ is the rate of new smokers due to peer pressure. $ \beta_2 R \frac{I}{N} $ is the relapse rate, which is also driven by peer pressure. $ \alpha I $ is the rate of temporary quitting. $ \gamma R $ is the rate of permanent quitting.

    In the study of epidemics models, it has become well known that the infection force $ \beta_1 S \frac{I}{N} $ is measured by the basic reproduction number. That is the well-known threshold phenomenon. When $ {{{\cal R}_{0}}} > 1 $, the disease takes off; and $ {{{\cal R}_{0}}} < 1 $ the disease dies out. Now we are interested in how to measure the reinfection force (relapse rate) $ \beta_2 R \frac{I}{N} $ and the role of the reinfection force in determining the dynamics of the disease.

    The basic reproduction number for model (2.1) is given by

    $ R0=β1μ+α.
    $
    (2.2)

    But the dynamics of the model (2.1) can be described by two quantities: $ {{{\cal R}_{0}}} $ and

    $ Rr=(β2μ+α)(αμ+α)(μμ+γ).
    $
    (2.3)

    Theorem 2. Consider model $(2.1)$. When $ {{{\cal R}_{r}}} < 1 $, a forward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $; Conversely, when $ {{{\cal R}_{r}}} > 1 $, a backward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $.

    According to Theorem 2, the direction of bifurcation at $ {{{\cal R}_{0}}} = 1 $ is completely determined by $ {{{\cal R}_{r}}} $. We define $ {{{\cal R}_{r}}} = \left(\frac{\beta_2}{\mu+ \alpha}\right)\left(\frac{\alpha}{\mu+ \alpha} \right) \left(\frac{\mu}{\mu+ \gamma} \right) $ to be the basic reinfection number for the SIRT model (2.1). Formally, basic reinfection number, denoted by $ {{{\cal R}_{r}}} $, is defined to be the average number of reinfections of a typical infectious during entire infectious period in a subpopulation of all recovered individuals.

    The basic reinfection number $ {{{\cal R}_{r}}} $ in (2.3) has clear epidemiological and biological meaning. Exactly the same as $ {{{\cal R}_{0}}} $, $ {{{\cal R}_{r}}} $ measures both the availability of resources and capability to reinforce. Each term in the expression has clear demographic or epidemiological implication.

    Obviously, $ \beta_2 $ is the transmission rate of reinfection; $ \frac{1}{\mu+ \alpha} $ is the average reinfection period which is the same as the average infection period. The first part of the expression in (2.3) is the same as $ {{{\cal R}_{0}}} $, except the for reinfection rate. The second and the third parts imply that the reinfection takes place in the recovered subpopulation ($ R $). To become a member of the $ R $-class, an infected individual must recover from $ I $-class to $ R $-class. This occurs with the probability $ \alpha/(\alpha+\mu) $. Furthermore, an individual in $ R $-class can be reinfected only if the individual does not become a member of $ T $-class. This event happens with the probability $ \mu/(\gamma+\mu) $. Overall $ \left(\alpha/(\alpha+\mu)\right)\left(\mu/(\gamma+\mu)\right) $ gives the probability of contacting the recovered class. Comparing the expressions (2.3) and (2.2), it can be seen that the only difference is that they each apply to distinct sub-populations. The basic reproduction number is applied to the general susceptible population (naive population). The probability of contacting the susceptible class is one because it is assumed that all individuals are susceptible from the definition of $ {{{\cal R}_{0}}} $. However, this is not the case for basic reinfection number, since reinfections take place only if the recovered population is established. The term $ \left(\alpha/(\alpha+\mu)\right)\left(\mu/(\gamma+\mu)\right) $ in (2.3) is exact the probability of the establishment of the recovered population. Therefore, the basic reinfection number is applied to the recovered population. In short, the basic reproduction number takes care of the primary infections and the basic reinfection number accounts for reinfections, which were missing in $ {{{\cal R}_{0}}} $ (It is beyond the reach of $ {{{\cal R}_{0}}} $).

    Below, we mathematically prove Theorem 2.

    Proof. The Jacobian of system (2.1) around the smoking-free equilibrium $ (N, 0, 0, 0) $ is given by

    $ J DFE =(μβ1000β1(α+μ)000α(μ+γ)000γμ).
    $

    Choosing $ \beta_1 $ as the bifurcation parameter, then $ {{{\cal R}_{0}}} = 1 $ corresponds to $ \beta_1 = \beta^*_1 = \mu+ \alpha $. It can be seen that $ \lambda = 0 $ is a simple eigenvalue of the matrix $ J_{(\text{DFE,} \beta = \beta^*_1)} $. A right and left eigenvector corresponding to the zero eigenvalue are $ \mathbf{W}' = [w_1, w_2, w_3, w_4] = [- \frac{\beta_1^*}{\mu}, 1, \frac{ \alpha}{\mu+ \gamma}, \frac{ \alpha \gamma}{\mu(\mu+ \gamma)}] $ and $ \mathbf{V} = [v_1, v_2, v_3, v_4] = [0; 1; 0; 0]$, respectively. Using formula of (1.2) and (1.3), we obtain $ b = \frac{\Lambda}{\mu} > 0 $ and $ a = 2\beta_1^*w_1w_2+2 \frac{ \beta_2 \alpha }{\mu + \gamma} $ which can be conveniently expressed as $ \frac{a}{2} = \frac{ \beta_2 \alpha }{\mu + \gamma}- \frac{(\mu+ \alpha)^2}{\mu} $. Therefore, a backward bifurcation occurs if $ \frac{ \beta_2 \alpha }{\mu + \gamma}- \frac{(\mu+ \alpha)^2}{\mu} > 0 $. It is equivalent to $ \left(\frac{\beta_2}{\mu+ \alpha}\right)\left(\frac{ \alpha}{\mu+ \alpha} \right) \left(\frac{\mu}{\mu+ \gamma} \right) > 1 $, i.e. $ {{{\cal R}_{r}}} > 1 $. Applying Theorem 1, Theorem 2 follows.

    This section demonstrates the basic reinfection numbers in some epidemic models for tuberculosis and socially transmitted diseases.

    For more general tuberculosis (TB) exogenous reinfection models, we refer the reader to [15,21]. Here, we construct a simpler model to illustrate the infection number. Basically, we assume that successfully treated individuals are still susceptible individuals. The host population is divided into the following three epidemiological classes: susceptible (S), exposed (L, infected but not infectious), infectious (I), and successfully treated individuals are still susceptible. Let $ N $ denote the total population size. The model takes the following ODE form of three equations:

    $ {dSdt=Λβ1SINμS+r2L+r1I,dLdt=β1SINβ2LIN(μ+k+r2)L,dIdt=β2LIN+kL(μ+d+r1)I.
    $
    (3.1)

    Here, $ \Lambda $ is the recruitment rate of the population; $ \beta_1 $ is the average number of effective contacts a susceptible has per unit of time; $ \beta_2 $ is the average number of effective contacts an exposed individual has per unit of time. $ \mu $ is the per-capita natural death rate; $ k $ is the primary progression rate at which an exposed individual leaves the latent class by becoming a member of an infectious class; $ d $ is the per-capita disease-induced death rate; $ r_2 $ and $ r_1 $ are the per-capita treatment rates for the exposed and the infected, respectively. The term $ \beta_2L\frac{I}{N} $ models the exogenous reinfection rates. The treated infections and exposed become members of susceptible class. The basic reproduction number for (3.1) is

    $ R0=(β1μ+d+r1)(kμ+k+r2).
    $

    Because of the exogenous reinfection, model (3.1) undergoes a richer dynamics due to the occurrence of backward bifurcation, which can be characterized by the basic reinfection number.

    The basic reinfection number for model (3.1) is

    $ Rr=(β2μ+d+r1+k)(μ+r2μ+k+r2).
    $
    (3.2)

    Again, we conclude that the basic reinfection number characterizes the occurrence of backward bifurcation. We formally summarize this result into theorem 3 below. The proof of this theorem can be found in Appendix A.

    Theorem 3. Consider model $(3.1)$. The basic reinfection number is given by equation $(3.2)$. When $ {{{\cal R}_{r}}} < 1 $, a forward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $; Conversely, when $ {{{\cal R}_{r}}} > 1 $, a backward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $.

    Similar to the interpretation to the basic reinfection number for SIRT model (2.1), here is an explanation to the basic infection number for model (3.1). $ \frac{\mu+r_2}{\mu+k+r_2} $ is the fraction of exposed population that does not naturally progress to active TB. This is the target population for exogenous reinfections. Only this portion of exposed population can be reinfected. It was observed that $ \frac{1}{\mu+d+r_1+k} $ tends to be the average reinfection period, which is shorter than the average primary infection period $ \frac{1}{\mu+d+r_1} $.

    A perfect match of basic reproduction number and the basic reinfection number can be identified in an extreme case where $ k = 0 $. In this case, $ {{{\cal R}_{0}}} = 0 $ and there is no primary progression and all new cases are the results of the exogenous reinfections. It is amazing that $ {{{\cal R}_{r}}} = \frac{ \beta_2}{\mu+d+r_1} $ has the exactly same formula as the basic reproduction number. If this number is greater than one, then there is possibility that the disease becomes endemic. If the number is less than one, the disease dies out. This study has observed an incredible result: a disease can become endemic even though the basic reproduction number is equal to zero provided that there are reinfections and basic reinfection number is bigger then one.

    Though regular mycobacterium tuberculosis is curable, it takes eight months to clear the bacterium with a complete treatment regime of antibiotics. Incomplete treatment puts the patient at higher risk of developing antibiotic resistance. Now we extend our model in previous subsection to consider multiple strains of tuberculosis infections. An antibiotic sensitive strain of TB and an antibiotic resistant strain are considered. Our goal is to naturally extend our basic reinfection number from one strain to multiple strains.

    Notations are the same as model (3.1). Here, we simply add subscripts to distinguish the different strains. The first strain is drug-sensitive and the second is drug-resistant. Let $ L_1 $ and $ L_2 $ denote individuals exposed to regular tuberculosis (antibiotic sensitive) and antibiotic resistant tuberculosis, respectively. Likewise, $ I_1 $ and $ I_2 $ stand for infectious individuals of antibiotic sensitive and antibiotic resistant, respectively. Treatments are applied to both the exposed and the infectious of the sensitive strain. $ p $ is the proportion of exposed individuals of antibiotic sensitive who did not complete their treatment and develop into antibiotic resistance. $ 1-p $ is the proportion of successfully treated exposed individuals. Hence, the treatment rate $ r_2L_1 $ for the exposed class is broken into successful treatment rate $ (1-p)r_2L_1 $ and unsuccessful treatment rate $ pr_2L_1 $. The former becomes member of $ S $ class, the latter goes to $ L_2 $ class. Let $ q $ be the proportion of infectious individuals of antibiotic sensitive who did not complete their treatment and develop into antibiotic resistant; $ 1-q $ be the proportion of successful treatment for infectious individuals. Among total treatment rate of $ r_1I_1 $, $ qr_1 I_1 $ gives the rate at which individuals develop resistant tuberculosis; and $ (1-q)r_1 I_1 $ goes to $ S $ class as the result of successful treatment. The model takes the following form of ordinary differential equations:

    $ {dSdt=Λβ1(I1+I2)NSμS+(1p)r2L1+(1q)r1I1,dL1dt=β1I1NSβ2I1NL1(μ+k1+r2)L1,dL2dt=β1I2NS+pr2L1+qr1I1β2I2NL2(μ+k2)L2,dI1dt=β2I1NL1+k1L1(μ+d1+r1)I1,dI2dt=β2I2NL2+k2L2(μ+d2)I2.
    $
    (3.3)

    Computations in Appendix D show that $ {\cal R}_0^1 = \left(\frac{\beta_1}{\mu+d_1+r_1}\right) \left(\frac{k_1}{\mu+k_1+r_2}\right) $ is the basic reproduction number for drug-sensitive strain and $ {\cal R}_0^2 = \left(\frac{\beta_1}{\mu+d_2}\right)\left(\frac{k_2}{\mu+k_2}\right) $ is the basic reproduction number for drug-resistant strain. Then the basic reproduction number for whole system is

    $ R0=max{(β1μ+d1+r1)(k1μ+k1+r2),(β1μ+d2)(k2μ+k2)}.
    $
    (3.4)

    In Appendix D, a detailed computation for formula (3.4) is presented.

    The situation is similar to that of the basic reproduction number (3.4). For each strain of TB, there is a corresponding basic reinfection number. The basic reinfection number for sensitive strain is

    $ R1r=(β2μ+d1+r1+k1)(μ+r2μ+r2+k1),
    $

    which is derived from Theorem 1 by assuming $ {\cal R}_0^1 > {\cal R}_0^2 $. On the other hand, if $ {\cal R}_0^1 < {\cal R}_0^2 $, the basic reinfection number for resistant strain of TB is

    $ R2r=(β2μ+d2+k2)(μμ+k2).
    $

    Hence, the basic reinfection number for the entire system is

    $ Rr={(β2μ+d1+r1+k1)(μ+r2μ+r2+k1), if  R10>R20(β2μ+d2+k2)(μμ+k2), if   R10<R20
    $
    (3.5)

    Theorem 4. Consider model $(3.3)$. The basic reinfection number is given by $(3.5)$. When $ {{{\cal R}_{r}}} < 1 $, a forward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $; Conversely, when $ {{{\cal R}_{r}}} > 1 $, a backward bifurcation occurs at $ {{{\cal R}_{0}}} = 1 $.

    We conclude again that the basic reinfection number controls the occurrence of backward bifurcation. Biological interpretation for the basic infection number is exactly the same as (3.2) of TB model (3.1) for a single strain. Both resistant strain and sensitive strain include the exogenous reinfection which causes the occurrence of backward bifurcations. What if both strains generate bi-stability? Numerically, tri-stability dynamics were found in [28]. That is, a collision of two backward bifurcations is able to generate tri-stability dynamics. We refer the interested readers to the examples in [28].

    Children who smoked once before age 11 are twice as likely to become a regular smoker by age 14 [37]. This is so called the sleeper effects. In this subsection, we present a mathematical model to study the dynamics of smoking in the United States among children ages 11 to 18 [38].

    All children enter the system as susceptible non-smokers with either little or no smoking history. Consequently, a two-string SIRT model is constructed, where string $ 1 $ is composed of individuals who smoked once before age 11, and string $ 2 $ is composed of those who did not. Using this model, the "sleeper effect" can be investigated.

    Each string is composed of four classes; $ N_i $, $ S_i $, $ Q_i $ (where $ i = 1, 2 $ denotes the respective string), and $ P $. The susceptible non-smoker classes ($ N_i $) are composed of individuals who have never been regular smokers. The regular smoker classes ($ S_i $) are composed of smokers. The recovered classes ($ Q_i $) are composed of individuals who have quit smoking but are susceptible to relapse. The class of permanent non-smokers ($ P $) is composed of individuals who have decided to permanently quit (from $ Q_i $).

    Individuals who turn 11 years old enter either $ N_1 $ or $ N_2 $ with rates $ \mu rT $ and $ \mu \left(1-r \right)T $, respectively, where $ T $ is the total population of adolescents. Non-smokers ($ N_i $) are susceptible to becoming regular smokers as a result of interactions with regular smokers ($ S_i $). Smokers ($ S_i $) can quit smoking due to personal choice or education. Individuals who have quit ($ Q_i $) can relapse due to social interactions with smokers. All individuals who are not currently regular smokers ($ N_i $, $ Q_i $) can move to class $ P $ by choosing to permanently abstain from cigarettes. We assume the total population, $ T $, is constant. Definitions of all model parameters are shown in Table 1. The following mathematical model was proposed in [38].

    $ {dN1dt=rμTβ1N1S1+S2TμN1,dN2dt=(1r)μTβ2N2S1+S2TμN2,dS1dt=β1N1S1+S2T+ψ1Q1S1+S2T(ϕ1+μ)S1,dS2dt=β2N2S1+S2T+ψ2Q2S1+S2T(ϕ2+μ)S2,dQ1dt=ϕ1S1ψ1Q1S1+S2T(α1+μ)Q1,dQ2dt=ϕ2S2ψ2Q2S1+S2T(α2+μ)Q2,dPdt=α1Q1+α2Q2μP,T=N1+N2+Q1+Q2+S1+S2+P.
    $
    (3.6)
    Table 1.  Parameter Definitions.
    Parameter Definition
    $\mu$ The rate of leaving a class as a result of aging or death
    It is also the recruitment rate
    $r$ Fraction of adolescents who smoked before age $11$
    $\beta_i$ Conversion rate of new smokers
    $\phi_i$ Rate at which individuals quit smoking
    $\psi_i$ Relapse rate
    $\alpha_i$ Rate at which individuals permanently quit smoking

     | Show Table
    DownLoad: CSV

    The equations of $ N_1 $, $ S_1 $ and $ Q_1 $ in model (3.6) describe the dynamics of the population that smoked at least once before age 11. Likewise, the equations of $ N_2 $, $ S_2 $ and $ Q_2 $ describe the dynamics of the population that did not smoke before age 11.

    The basic reproduction number for model (3.6) is

    $ R0=rβ1ϕ1+μ+(1r)β2ϕ2+μ.
    $
    (3.7)

    $ \frac{\beta_1}{\phi_1+\mu} $ is the basic reproduction number of subpopulation with a smoking history and $ \frac{\beta_2}{\phi_2+\mu} $ is the basic reproduction numbers of subpopulation without a smoking history. The overall basic reproduction number is the weighted average of the basic reproduction numbers for these two populations using $ r $ and $ (1-r) $ as the weights.

    The general structure of model (3.6) is almost the same as model (2.1). Since each string of (3.6) has the same structure as (2.1), we then expect to observe the same structure of basic reinfection number. To highlight the role of the basic reinfection number in this research, we here consider a simpler case where that $ \beta_1 = \beta_2 $.

    The basic reinfection number for model (3.6) is

    $ Rr=rψ1ϕ1+μϕ1ϕ1+μμα1+μ+(1r)ψ2ϕ2+μϕ2α2+μμα2+μ,
    $
    (3.8)

    where $ \left(\frac{\psi_1}{\phi_1+\mu}\right)\left(\frac{\phi_1}{\phi_1+\mu}\right) \left(\frac{\mu}{ \alpha_1+\mu}\right) $ is the basic reinfection number of subpopulation with a smoking history before age 11. Likewise, $ \left(\frac{\psi_2}{\phi_2+\mu}\right) \left(\frac{\phi_2}{ \alpha_2+\mu}\right)\left(\frac{\mu}{ \alpha_2+\mu}\right) $ is the basic reinfection number of subpopulation without a smoking history before age 11.

    To interpret the meaning of $ \frac{\psi_1}{\phi_1+\mu} \frac{\phi_1}{\phi_1+\mu} \frac{\mu}{ \alpha_1+\mu} $, we break it into two components. $ \frac{\psi_1}{\phi_1+\mu} $ is the average of relapse due to a typical smoker with smoking history before age 11 since $ \psi_1 $ is the relapse rate and $ \frac{1}{\phi_1+\mu} $ is the average smoking period in $ S_1 $. The second part $ \frac{\phi_1}{\phi_1+\mu} \frac{\mu}{ \alpha_1+\mu} $ finds the proportion of potential relapse population, because $ \frac{\phi}{\phi_1+\mu} $ is the proportion of quitting in $ S_1 $, and $ \frac{\mu}{\alpha_1+\mu} $ is the proportion of not permanent abstaining from cigarettes smoking of $ Q_1 $ class.

    The overall basic reinfection number (3.8) is the weighted average of the basic reinfection numbers of two subpopulations using $ r $ and $ (1-r) $ as the weights. It has the same format as the basic reproduction number (3.7).

    We have already achieved the same conclusion that if $ {{{\cal R}_{r}}} > 1 $, the model (3.6) undergoes a backward bifurcation at $ {{{\cal R}_{0}}} = 1 $. Such a statement is justified rigorously in Appendix C.

    If relapse does not come into play, i.e., $ \psi_i = 0 $, then $ {{{\cal R}_{r}}} = 0 < 1 $ and consequently backward bifurcation cannot happen. Namely, $ {{{\cal R}_{r}}} > 1 $ happens uniquely because of the relapse. To handle with cigarette smoking in adolescence, relapse must be avoided by all means.

    The reinfection forces (or capability of relapse) is successfully measured by the basic reinfection numbers, the identical role that basic reproduction number plays for the primary infection forces. A primary infection invades a population if the basic reproduction number is greater than one. If reinfection or relapse exist, the basic reinfection indicates a successful invasion of a disease into a population even when the basic reproduction number is less than one. Not only does the basic reinfection number $ {{{\cal R}_{r}}} $ quantify the reinfection forces, but also specifies the type of bifurcation at the basic reproduction number $ {{{\cal R}_{0}}} = 1 $.

    In reconsidering the remarkable observation from model (3.1) for tuberculosis, where the disease is still able to spread when the basic reproduction number is equal to zero, we may want to combine $ {{{\cal R}_{0}}} $ and $ {{{\cal R}_{r}}} $ together for a complete elimination of the disease. For instance, max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} $ would be a more proper control number, since the disease dies out when max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} < 1 $ regardless the initial epidemiological status. On one hand, max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} $ can be applied to epidemic models without reinfections because, when there is no reinfection, the basic reinfection number $ {{{\cal R}_{r}}} = 0 $, subsequently max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} = {{{\cal R}_{0}}} $. On the other hand, more important observation is that max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} $ is able to explain why an infectious disease can spread when $ {{{\cal R}_{0}}} = 0 $. Therefore, as an indicator whether the disease can take off or not, max$ \{{{{\cal R}_{0}}}, {{{\cal R}_{r}}}\} $ is better than $ {{{\cal R}_{0}}} $ alone.

    Using a few of deterministic epidemic models, we intend to introduce a new concept in theoretic epidemiology. The basic reinfection number $ {{{\cal R}_{r}}} $ has successfully characterized the occurrence of backward bifurcations for a large number of epidemic models. But we found that it is unsuccessful for the appearance of backward bifurcations caused by vaccination factor or nonlinear treatment rate[17,31,33]. Further research would find a corresponding counterpart for the epidemiological model where vaccination matters or nonlinear treatments are applied.

    Unlike $ {{{\cal R}_{0}}} $, which has been well formulated by using the next generation operator [13,18,36], in this paper we do not have a universal formula for $ {{{\cal R}_{r}}} $. Our approach to formulate it is to compute $ a $ and $ b $ from Theorem 1. Then manage the inequality $ a > 0 $ in order to find the basic reinfection number. Future work may be devoted to formulate $ {{{\cal R}_{r}}} $ in general scenarios.

    In the range of $ {{{\cal R}_{0}}} < 1 $, if reinfection force is strong enough to make $ {{{\cal R}_{r}}} > 1 $, the disease may be persistent even when the primary infection cannot support an endemic. This does not work for the full range of $ {{{\cal R}_{0}}} < 1 $, because when the basic reproduction number is too small, there are not enough recovered individuals to be reinfected. That is why any backward bifurcation curve eventually has to turn around, as can be seen in Figure 4.

    Figure 2.  Diagram of model for cigarette smoking. Relapse of cigarette smoking is highlighted.
    Figure 3.  Diagram of tuberculosis transmission (3.1).
    Figure 4.  A backward bifurcation of system (3.1). This figure is generated by letting $ \beta_1 $ change from $ 0.2 $ to $ 0.45 $, and $ \beta_2 = 5 $, $ \mu = 0.15 $, $ k = 0.1 $, $ r_1 = r_2 = 0.01 $, $ d = 0 $. The corresponding basic reinfection number $ {{{\cal R}_{r}}} = 11.83 > 1 $.
    Figure 5.  Diagram of TB model (3.3) of two strains.
    Figure 6.  Diagram of model for cigarettes smoking among young adults. Two-strain model is adopted to take consideration of sleeper effects.

    The author declares that there is no conflict of interest regarding the publication of this paper.

    Here we show how to get the reinfection number for model (3.1). The Jacobian of the system (3.1) around the TB-free equilibrium is

    $ J = \left[μr2r1β10(μ+k+r2)β10k(μ+d+r1)
    \right]. $

    When $ {{{\cal R}_{0}}} = \left(\beta_1/(\mu+d+r_1)\right)\left(k/(\mu+k+r_2)\right) = 1 $, a left eigenvector of $ J $ is $ \mathbf{V} = \left[v1v2v3

    \right] = \left[0v2v2(μ+k+r2)/k
    \right] $ and a right eigenvector is $ \mathbf{W}' = \left[w_1, w_2, w_3\right] $ $ = \left[w_2(r_2+(\mu+k+r_2)(r_1-\beta_1)/\beta_1)/\mu, w_2, w_2(\mu+k+r_2)/\beta_1 \right] $. Choosing $ v_2 = w_2+1 $ with any $ w_2 > 0 $, we obtain that

    $ b=v2w2>0,anda=v23i,j=1wiwj2f2xixj+v33i,j=1wiwj2f3xixj=2v2w2w3(β1+β2)μ/Λ2v2w3w3β1μ/Λ+2v3w2w3β2μ/Λ.
    $

    To single out the sign of $ a $, we rewrite the last equation as

    $ a(kΛ/(2v3w2w3μ))=β2(μ+r2)(μ+k+r2)(μ+d+r1+k)
    $

    Obviously, $ a > 0 $ if and only if $ \left(\frac{ \beta_2}{\mu+d+r_1+k}\right)\left(\frac{\mu+r_2}{\mu+k+r_2}\right) > 1 $. Then

    $ {{{\cal R}_{r}}} = \left( \frac{ \beta_2}{\mu+d+r_1+k}\right)\left( \frac{\mu+r_2}{\mu+k+r_2}\right) $

    is the basic reinfection number. Applying Theorem 1, we conclude our proof.

    We choose $ \beta_1 $ as the bifurcation parameter. Denote the right-hand functions of (3.3) by $ f_1 $, $ f_2 $, $ f_3 $, $ f_4 $, $ f_5 $; and the state variables $ (S, L_1, L_2, I_1, I_2) $ are denoted by $ (x_1, x_2, x_3, x_4, x_5) $. Set $ K = \frac{\Lambda}{\mu} $ for a shortcut.

    Applying theorem 1, we directly compute $ a $ and $ b $. The Jacobian of the system evaluated at the TB-free equilibrium $ (\Lambda/\mu, 0, 0, 0, 0) $ is

    $ J=[μ(1p)r20(1q)r1β1β10(μ+k1+r2)0β100pr2(μ+k2)qr1β10k10(μ+d1+r1)000k20(μ+d2)].
    $
    (12.1)

    Comparing with one-strain TB model (3.1), we here have to additionally deal with whether $ {{{\cal R}_{0}}} = {\cal R}_0^1 = \left(\frac{\beta_1}{\mu+d_1+r_1}\right) \left(\frac{k_1}{\mu+k_1+r_2}\right) $ or $ {{{\cal R}_{0}}} = {\cal R}_0^2 = \left(\frac{\beta_1}{\mu+d_2}\right)\left(\frac{k_2}{\mu+k_2}\right) $ because the overall basic reproduction number is $ {{{\cal R}_{0}}} = \text{max} \left\{{\cal R}_0^1, {\cal R}_0^2 \right\} $. For convenience, we tabulate the non-zero second derivatives ($ \partial^2f_k/\partial x_i \partial x_j $, $ i, j, k = 1\cdots 5 $) evaluated at the TB-free equilibrium $ (\Lambda/\mu, 0, 0, 0, 0) $ and $ {{{\cal R}_{0}}} = 1 $ in Table 2.

    Table 2.  non-zero second derivatives.
    $ \frac{{\partial}^2f_2}{\partial x_2 \partial x_4}=- \frac{\beta_1+\beta_2}{K} $ $ \frac{{\partial}^2f_2}{\partial x_3 \partial x_4}=- \frac{\beta_1}{K} $ $ \frac{{\partial}^2f_2}{\partial x_4^2}=- \frac{2\beta_1}{K} $ $ \frac{{\partial}^2f_2}{\partial x_4 \partial x_5}=- \frac{\beta_1}{K} $ $ \frac{{\partial}^2f_4}{\partial x_2 \partial x_4}= \frac{\beta_2}{K} $
    $ \frac{{\partial}^2f_3}{\partial x_2 \partial x_5}=- \frac{\beta_1}{K} $ $ \frac{{\partial}^2f_3}{\partial x_3 \partial x_5}=- \frac{\beta_1+\beta_2}{K} $ $ \frac{{\partial}^2f_3}{\partial x_4 \partial x_5}=- \frac{\beta_1}{K} $ $ \frac{{\partial}^2f_3}{ \partial x_5^2}=-2 \frac{\beta_1}{K} $ $ \frac{{\partial}^2f_5}{\partial x_3 \partial x_5}= \frac{\beta_2}{K} $

     | Show Table
    DownLoad: CSV

    If $ {\cal R}_0^1 > {\cal R}_0^2 $, then $ {{{\cal R}_{0}}} = 1 $ means $ {\cal R}_0^1 = 1 $. A left eigenvector of (B.1) at $ {\cal R}_0^1 = 1 $ is $ \mathbf{V} = [v_1, v_2, v_3, v_4, v_5] = [0, \frac{k_1}{\mu+r_2+k_1}v_4, 0, v_4, 0] $, where $ v_4 $ is free. A right eigenvector is $ \mathbf{W} = \left[w_1, w_2, w_3, w_4, w_5\right]' $, where

    $ w1=w1(no impact),w2=μ+d1+r1k1w4,w3=k2(pr2(μ+d1+r1)+qr1k1)k1(μ+k2)(μ+d2)k2(μ+d1+r1)(μ+k1+r2),w4=free,w5=(μ+d2)(pr2(μ+d1+r1)+qr1k1)k1(μ+k2)(μ+d2)k2(μ+d1+r1)(μ+k1+r2).
    $

    It can be checked $ b = \frac{k_1}{\mu+r_2+k_1}v_4w_4 > 0 $. To compute $ a $, we need to pay attention to $ f_2 $ and $ f_4 $ only because $ v_1 = v_3 = v_5 = 0 $.

    $ a=v25i,j=1wiwj2f2xixj+v4ni,j=1wiwj2f4xixj
    $

    Looking up Table 2, we obtain that

    $ a=2v2(w2w42f2x2x4+w242f2x24+w3w42f2x3x4+w5w42f2x5x4)+2v4w2w42f4x2x4a(K2v2w2w4)=(β1+β2)β1w4w2+β2v4v2=(β1+β2)β1k1μ+d1+r1+β2μ+k1+r2k1=β2μ+r2k1(μ+d1+r1+k1)(μ+k1+r2)k1
    $

    Therefore, $ a > 0 $ iff $ \beta_2(\mu+r_2) > (\mu+d_1+r_1+k_1)(\mu+k_1+r_2) $, i.e. $ \frac{\beta_2}{\mu+r_1+d_1+k_1} \frac{\mu+r_2}{\mu+k_1+r_2} > 1 $. Then the basic reinfection number for sensitive strain is

    $ R1r=(β2μ+d1+r1+k1)(μ+r2μ+k1+r2).
    $

    Now assume $ {\cal R}_0^1 < {\cal R}_0^2 $. Then $ {{{\cal R}_{0}}} = 1 $ means $ {\cal R}_0^2 = 1 $. A left eigenvector of (12.1) at $ {\cal R}_0^2 = 1 $ is $ \mathbf{V} = [v_1, v_2, v_3, v_4, v_5] $, where $ v_1 = 0 $, $ v_2 = \frac{pr_2(\mu+d_1+r_1)+k_1qr_1}{k_2(\mu+d_1+r_1)(\mu+k_1+r_2)-k_1(\mu+d_2)(\mu+k_2)} \frac{k^2_2}{\mu+d_2}v_5 $, $ v_3 = \frac{k_2}{\mu+d_2}v_5 $, $ v_4 = \frac{k_2qr_1(\mu+k_1+r_2)+pr_2(\mu+d_2)(\mu+k_2)}{k_2(\mu+d_1+r_1)(\mu+k_1+r_2)-k_1(\mu+d_2)(\mu+k_2)} \frac{k_2}{\mu+d_2}v_5 $, and $ v_5 $ is free. A right eigenvector is $ \mathbf{W}' = \left[w_1, w_2, w_3, w_4, w_5\right] = \left[(μ+k2)(μ+d2)μk2w5,0,μ+d2k2w5,0,w5

    \right] $. $ w_5 $ is free. $ w_2 = w_4 = 0 $ makes the computation of $ a $ a lot easier.

    $ a=v25i,j=1wiwj2f2xixj+v3ni,j=1wiwj2f4xixjv45i,j=1wiwj2f2xixj+v5ni,j=1wiwj2f4xixj=v3(2w2w52f3x2x5+2w3w52f3x3x5+2w4w52f3x4x5+w252f3x25)+2v5w3w52f5x3x5=v3(2w3w52f3x3x5+w252f3x25)+2v5w3w52f5x3x5
    $
    $ av3w3w5=(22f3x3x5+w5w32f3x25)+2v5v32f5x3x5=2β1+β2K2k2μ+d2β1K+μ+k2k2β2KaK2v3w3w5=β1β2k2μ+d2β1+μ+k2k2β2=β1μ+d2+k2μ+d2+μβ2k2=(μ+k2)(μ+d2+k2)k2+μβ2k2
    $

    Therefore, $ a > 0 $ iff $ \mu\beta_2 > (\mu+k_2)(\mu+d_2+k_2) $, i.e. $ \frac{\beta_2}{\mu+d_2+k_2} \frac{\mu}{\mu+k_2} > 1 $. Then the basic reinfection number for resistant strain is

    $ R2r=(β2μ+d2+k2)(μμ+k2).
    $

    The basic reinfection number for entire system is

    $ {{{\cal R}_{r}}} = {(β2μ+d2+k2)(μμ+k2), if   R10>R20(β2μ+d1+r1+k1)(μ+r2μ+r2+k1), if   R10<R20
    $

    The basic reinfection number for model (3.6) is derived in a simple case $ \beta_1 = \beta_2 = \beta $. We look at the Jacobian of the system evaluated at the smoker-free equilibrium $ (rT, (1-r)T, 0, 0, 0, 0, 0) $

    $ J = \left[μ0βrβr0000μβ(1r)β(1r)00000βr(ϕ1+μ)βr00000β(1r)β(1r)(ϕ2+μ)00000ϕ10(α1+μ)00000ϕ20(α2+μ)00000α1α2μ
    \right]. $

    Choose $ \beta $ as the bifurcation parameter. Apparently $ {{{\cal R}_{0}}} = 1 $ corresponds to $ \beta = \beta^* = \frac{(\phi_1 + \mu)(\phi_2 + \mu)}{r(\phi_2 + \mu)+(1-r)(\phi_1 + \mu)} $. A right eigenvector associated with the eigenvalue $ \lambda = 0 $ of $ J $ is $ \mathbf{W}' = \left[w_1, w_2, w_3, w_4, w_5, w_6, w_7 \right] $, where

    $ w1=r(ϕ2+μ)(1r)μw4,w2=ϕ2+μμw4,w3=r(ϕ2+μ)(1r)(ϕ1+μ)w4>0,w4=(1+r(ϕ2+μ)(1r)(ϕ1+μ)(ϕ2+μ)(ϕ1+μ))1>0,w5=ϕ1α1+μr(ϕ2+μ)(1r)(ϕ1+μ)w4,w6=ϕ2α2+μw4,w7=α1μϕ1α1+μr(ϕ2+μ)(1r)(ϕ1+μ)w4+α2μϕ2α2+μw4.
    $

    A left eigenvector associated with the eigenvalue $ \lambda = 0 $ of $ J $ is $ \mathbf{V} = [v_1, v_2, v_3, v_4, v_5, v_6, v_7] = \left[0, 0, \frac{\phi_2+\mu}{\phi_1+\mu}, 1, 0, 0, 0\right] $. Without confusion, we set $ f_i $ to be the right-hand side functions of system (3.6) and denote $ [N_1, N_2, S_1, S_2, Q_1, Q_2, P] $ by $ [x_1, x_2, x_3, x_4, x_5, x_6, x_7] $. Because of $ v_1 = v_2 = v_5 = v_6 = v_7 = 0 $, only $ f_3 $ and $ f_4 $ matter when calculating $ a $ and $ b $.

    Applying Theorem 1 to model (3.6), we obtain that

    $ b=v37i,j=1wiwj2f3xiβ+v47i,j=1wiwj2f4xiβ=rv3(w3+w4)+(1r)v4(w3+w4)=(r(ϕ2+μ)+(1r)(ϕ1+μ))2r(ϕ2+μ)2+(1r)(ϕ1+μ)2>0.
    $
    $ a=v37i,j=1wiwj2f3xixj+v47i,j=1wiwj2f4xixj=v3[2w1w32f3x1x3+2w1w42f3x1x4+2w3w52f3x3x5+2w4w52f3x4x5]+v4[2w2w32f4x2x3+2w2w42f4x2x4+2w3w62f4x3x6+2w4w62f4x4x6]=2(w3+w4)T(v3βw1+v3ψ1w5+βw2+ψ2w6)
    $

    Organize the above expression to check the sign of $ a $. Noticing $ w_3 > 0 $ and $ w_4 > 0 $.

    $ aT2(w3+w4)w4=β[r(ϕ2+μ)(1r)μϕ2+μϕ1+μϕ2+μμ]+ψ1ϕ1α1+μr(ϕ2+μ)(1r)(ϕ1+μ)+ψ2ϕ2α2+μ=βϕ2+μμ[r(1r)ϕ2+μϕ1+μ+1]+ψ1ϕ1α1+μr(ϕ2+μ)(1r)(ϕ1+μ)+ψ2ϕ2α2+μ=(ϕ2+μ)2μ(1r)+ψ1ϕ1α1+μr(ϕ2+μ)(1r)(ϕ1+μ)+ψ2ϕ2α2+μ
    $

    It can be seen that $ a > 0 $ if and only if

    $ \psi_1 \frac{\phi_1}{\alpha_1+\mu} \frac{r(\phi_2+\mu)}{(1-r)(\phi_1+\mu)} +\psi_2 \frac{\phi_2}{\alpha_2+\mu} > \frac{(\phi_2+\mu)^2}{\mu (1-r)}, $

    which is equivalent to

    $ r \frac{\psi_1}{\phi_1+\mu} \frac{\phi_1}{\phi_1+\mu} \frac{\mu}{ \alpha_1+\mu}+ (1-r) \frac{\psi_2}{\phi_2+\mu} \frac{\phi_2}{ \alpha_2+\mu} \frac{\mu}{ \alpha_2+\mu} > 1. $

    Consequently, the basic reinfection number for model (3.6) is

    $ {{{\cal R}_{r}}} = r\left( \frac{\psi_1}{\phi_1+\mu}\right)\left( \frac{\phi_1}{\phi_1+\mu}\right) \left( \frac{\mu}{ \alpha_1+\mu}\right)+ (1-r)\left( \frac{\psi_2}{\phi_2+\mu}\right) \left( \frac{\phi_2}{ \alpha_2+\mu}\right)\left( \frac{\mu}{ \alpha_2+\mu}\right). $

    The approach of next-generation operator [18] is used to calculate the basic reproduction number $ {{{\cal R}_{0}}} $ for model (3.3).

    $ X = [L_1, L_2, I_1, I_2] $, $ \frac{dX}{dt} = F(X)-V(X) $, where

    $ F(X) = \left[β1I1KNβ2I2KN00

    \right] $ and $ V(X) = \left[β2I1NL1+(μ+k1+r2)L1pr2L1qr1I1+β2I2NL2+(μ+k2)L2β2I1NL1k1L1+(μ+d1+r1)I1β2I2NL2k2L2+(μ+d2)I2
    \right]. $

    $ {\cal F} = \left. \frac{\partial F}{\partial X}\right|_{X = 0} = \left[0β00

    \right] $ with $ \beta = \left[β100β1
    \right] $, and $ {\cal V} = \left.\frac{\partial V}{\partial X}\right|_{X = 0} = \left[v11v12v21v22
    \right] $, where $ v_{11} = \left[μ+k1+r20pr2μ+k2
    \right] $, $ v_{12} = \left[00qr10
    \right] $, $ v_{21} = \left[k100k2
    \right] $, and $ v_{22} = \left[μ+d1+r100μ+d2
    \right] $. A block format of $ {\cal V}^{-1} = \left[γ11γ12γ21γ22
    \right] $. Since $ {\cal F}{\cal V}^{-1} = \left[βγ21βγ2200
    \right] $, the spectrum radius of $ {\cal F}{\cal V}^{-1} $ is determined by $ \beta\gamma_{21} $. Using block operations of matrices, one can find

    $ \gamma_{21} = \left[k1(μ+d1+r1)(μ+k1+r2)0k1(pr2+k1qr1μ+d1+r1)(μ+d1+r1)(μ+k1+r2)(μ+k2)k2(μ+d2)(μ+k2)

    \right] $. $ \beta\gamma_{21} = \left[β1k1(μ+d1+r1)(μ+k1+r2)0β1k1(pr2+k1qr1μ+d1+r1)(μ+d1+r1)(μ+k1+r2)(μ+k2)β1k2(μ+d2)(μ+k2)
    \right] $. Therefore

    $ R0=ρ(FV1)=max{(β1μ+d1+r1)(k1μ+k1+r2),(β1μ+d2)(k2μ+k2)},
    $

    and formula (3.4) is proved.

    [1] The Florida Center of Excellence in Drug Discovery and Innovation (CDDI) is described at: http://www.research.usf.edu/cddi/drugdiscovery/resources.asp.
    [2] Huang YM, Amsler AO, McClintock JB, et al. (2007) Patterns of gammarid amphipod abundance and species composition associated with dominant subtidal macroalgae along the western Antarctic Peninsula. Polar Biol 30: 1417-1430. doi: 10.1007/s00300-007-0303-1
    [3] Santiago DN, Pevzner Y, Durand AA, et al. (2012) Virtual Target Screening: Validation Using Kinase Inhibitors. J Chem Inf Model 52: 2192-2203. doi: 10.1021/ci300073m
    [4] Irwin JJ, Sterling T, Mysinger MM, et al. (2012) ZINC: A Free Tool to Discover Chemistry for Biology. J Chem Info Model 52:1757-1768. doi: 10.1021/ci3001277
    [5] Gerwick WH, Moore BS (2012) Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem Biol 19:85-98. doi: 10.1016/j.chembiol.2011.12.014
    [6] Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10: 507-519. doi: 10.1038/nrd3480
    [7] Newman DJ, Cragg GM (2012) Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J Nat Prod 75: 311-335. doi: 10.1021/np200906s
    [8] Mishra BB, Tiwari VK (2011) Natural products: An evolving role in future drug discovery. Eur J Med Chem 46: 4769-4807. doi: 10.1016/j.ejmech.2011.07.057
    [9] Bachmann BO, Van Lanen SG, Baltz RH (2014) Microbial genome mining for accelerated natural products discovery: is a renaissance in the making? J Indust Microbiol Biotech 41: 175-184. doi: 10.1007/s10295-013-1389-9
    [10] Williams P, Sorribasa A, Howes MR (2011) Natural products as a source of Alzheimer's drug leads. Nat Prod Rep 28: 48-77. doi: 10.1039/C0NP00027B
    [11] Kuete V, Alibert-Franco S, Eyong KO, et al. (2011) Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype. Int J Antimicrob Agents 37: 156-161. doi: 10.1016/j.ijantimicag.2010.10.020
    [12] Cragg GM, Newman DJ (2013) Natural products: A continuing source of novel drug leads. Biochim Biophys Acta 1830: 3670-3695. doi: 10.1016/j.bbagen.2013.02.008
    [13] Dayan FE, Owens DK, Duke SO (2012) Rationale for a natural products approach to herbicide discovery. Pest Mgmt Sci 68: 519-528. doi: 10.1002/ps.2332
    [14] Bugni TS, Harper MK, McCulloch MWB, et al. (2008) Fractionated marine invertebrate extract libraries for drug discovery. Molecules 13: 1372-1383. doi: 10.3390/molecules13061372
    [15] Molinski TF (2010) NMR of natural products at the “nanomole-scale”. Nat Prod Rep 27: 321-329. doi: 10.1039/b920545b
    [16] Nicolaou KC, Snyder SA (2005) Chasing molecules that were never there: misassigned natural products and the role of chemical synthesis in modern structure elucidation. Angew. Chem Int Ed Engl 44: 1012-1044. doi: 10.1002/anie.200460864
    [17] Penn K, Jenkins C, Nett M, et al. (2009) Genomic islands link secondary metabolism to functional adaptation in marine Actinobacteria. ISME J 3: 1193-1203. doi: 10.1038/ismej.2009.58
    [18] Lipinski CA, Lombardo F, Dominy BW, et al. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46: 3-26. doi: 10.1016/S0169-409X(00)00129-0
    [19] Ursu O, Rayan A, Goldblum A, et al. (2011) Understanding drug-likeness. WIREs: Comp Mol Sci 1:760-781. doi: 10.1002/wcms.52
    [20] Bickerton GR, Paoliuni GV, Besnard J, et al. (2012) Quantifying the chemical beauty of drugs. Nat Chem 4: 90-98. doi: 10.1038/nchem.1243
    [21] Matter H, Sotriffer C (2011) Applications and success stories in virtual screening. In: Virtual screening: principles, challenges, and practical guidelines. Wiley-VCH Verlag GmbH & Co. Ch. 12: 319-358.
    [22] Vangrevelinghe E, Zimmermann K, Schoepfer J, et al. (2003) Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking. J Med Chem 46: 2656-2662. doi: 10.1021/jm030827e
    [23] Ewing TA, Makino S, Skillman AG, et al. (2001) DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comp Mol Des 15: 411-428.
    [24] Friesner RA, Banks JL, Murphy RB, et al. (2004) Glide: New approach for rapid, accurate docking and scoring. 1. Method and Assessment of Docking Accuracy. J Med Chem 47: 1739-1749.
    [25] 26. Brooks WH, McCloskey DE, Daniel KE, et al. (2007) In Silico Chemical Library Screening and Experimental Validation of a Novel 9-Aminoacridine Based Lead-Inhibitor of Human S-Adenosylmethionine Decarboxylase. J Chem Info Model 47: 1897-1905. doi: 10.1021/ci700005t
    [26] 27. Tolbert WD, Ekstrom JL, Mathews II, et al. (2001) The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase. Biochemistry 40: 9484-9494. doi: 10.1021/bi010735w
    [27] 28. Berman HM, Westbrook J, Feng Z, et al. (2000) The Protein Data Bank. Nucl Acids Res 28: 235-242. doi: 10.1093/nar/28.1.235
    [28] 29. Hui-Fang L, Qing S, Jian Z, et al. (2010) Evaluation of various inverse docking schemes in multiple targets identification. J Mol Graph Model 29: 326-330. doi: 10.1016/j.jmgm.2010.09.004
    [29] 30. Grinter SZ, Liang Y, Huang SY, et al. (2011) An inverse docking approach for identifying new potential anti-cancer targets. J Mol Graph Model 795-799. doi: 10.1016/j.jmgm.2011.01.002
    [30] 31. Do QT, Lamy C, Renimel I, et al. (2007) Reverse Pharmacognosy: Identifying Biological Properties for Plants by Means of their Molecule Constituents: Application to Meranzin. Planta Med 73: 1235-1240. doi: 10.1055/s-2007-990216
    [31] 32. Li YY, An J, Jones SJM (2006) A Large-Scale Computational Approach to Drug Repositioning. Genome Info 17: 239-247.
    [32] 37. Miller BT, Singh RP, Klauda JB, et al. (2008) CHARMMing: a new, flexible web portal for CHARMM. J Chem Info Model 48: 1920-1929. doi: 10.1021/ci800133b
    [33] 38. Wang Y, Xiao J, Suzek TO, et al. (2012) PubChem's BioAssay Database. Nucl Acids Res 40: D400-12. doi: 10.1093/nar/gkr1132
    [34] 39. Bolton E, Wang Y, Thiessen PA, et al. (2008) PubChem: Integrated Platform of Small Molecules and Biological Activities. Chapter 12 in Annual Reports in Computational Chemistry, Volume 4, ACS, Washington, DC.
    [35] 42. Imhoff JF, Labes A, Wiese J (2011) Bio-mining the microbial treasures of the ocean: New natural products. Biotech Adv 29: 468-482. doi: 10.1016/j.biotechadv.2011.03.001
    [36] 43. Liu X, Ashforth E, Ren B, et al. (2010) Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J Antibiotics 63: 415-422. doi: 10.1038/ja.2010.56
    [37] 44. Bauer RA, Wurst JM, Tan DS (2010) Expanding the range of “druggable” targets with natural product-based libraries: an academic perspective. Curr Op Chem Biol 14: 308-314. doi: 10.1016/j.cbpa.2010.02.001
    [38] 45. Mayer AMS, Glaser KB, Cuevas C, et al. (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharm Sci 31: 255-265. doi: 10.1016/j.tips.2010.02.005
    [39] 46. Bennani YL (2011) Drug discovery in the next decade: innovation needed ASAP. Drug Disc Today 16:
    [40] 47. Keiser MJ, Setola V, Irwin JJ, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-182. doi: 10.1038/nature08506
    [41] 48. Reker D, Rodrigues T, Schneider P, et al. (2014) Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Natl Acad Sci USA 111: 4067-4072. doi: 10.1073/pnas.1320001111
    [42] 49. Liu X, Vogt I, Hague T, et al. (2013) HitPick: A web server for hit identification and target prediction of chemical screenings. Bioinformatics 29: 1910-1912. doi: 10.1093/bioinformatics/btt303
    [43] 50. Gong J, Cai C, Liu X, et al. (2013) ChemMapper: A versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics 29: 1827-1829. doi: 10.1093/bioinformatics/btt270
    [44] 51. Iorio F, Bosotti R, Scachen E, et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Nat Acad Sic USA 107: 14621-14626. doi: 10.1073/pnas.1000138107
    [45] 52. Zhu X, Kim JL, Newcomb JR, et al. (1999) Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Struct Fold Des 7: 651-661. doi: 10.1016/S0969-2126(99)80086-0
    [46] 53. Goto M, Miyahara I, Hirotsu K, et al. (2005) Structural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anticonvulsant drug gabapentin. J Biol Chem 280: 37237256. doi: 10.1074/jbc.M506486200
    [47] 55. Halgren T (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377-389. doi: 10.1021/ci800324m
  • This article has been cited by:

    1. Lusha Shi, Jianghong Hu, Zhen Jin, Dynamics analysis of strangles with asymptomatic infected horses and long-term subclinical carriers, 2023, 20, 1551-0018, 18386, 10.3934/mbe.2023817
    2. Guijie Lan, Sanling Yuan, Baojun Song, Threshold behavior and exponential ergodicity of an sir epidemic model: the impact of random jamming and hospital capacity, 2024, 88, 0303-6812, 10.1007/s00285-023-02024-1
    3. Indunil M. Hewage, Kevin E. M. Church, Elissa J. Schwartz, Investigating the impact of vaccine hesitancy on an emerging infectious disease: a mathematical and numerical analysis, 2024, 18, 1751-3758, 10.1080/17513758.2023.2298988
    4. Hui Cao, Baojun Song, Yicang Zhou, Treatment strategies for the latent tuberculosis infections, 2023, 86, 0303-6812, 10.1007/s00285-023-01927-3
    5. Marcelo A. Pires, Cesar I.N. Sampaio Filho, Hans J. Herrmann, José S. Andrade, Tricritical behavior in epidemic dynamics with vaccination, 2023, 174, 09600779, 113761, 10.1016/j.chaos.2023.113761
    6. Qiuyun Li, Fengna Wang, An Epidemiological Model for Tuberculosis Considering Environmental Transmission and Reinfection, 2023, 11, 2227-7390, 2423, 10.3390/math11112423
    7. Yousef Alnafisah, Moustafa El-Shahed, Optimal control of red palm weevil model incorporating sterile insect technique, mechanical injection, and pheromone traps, 2024, 93, 11100168, 382, 10.1016/j.aej.2024.02.059
    8. Shaoli Wang, Tengfei Wang, Ya-Nen Qi, Fei Xu, Backward bifurcation, basic reinfection number and robustness of an SEIRE epidemic model with reinfection, 2023, 16, 1793-5245, 10.1142/S1793524522501327
    9. Lucero Rodriguez Rodriguez, Marisabel Rodriguez Messan, Komi Messan, Yun Kang, Mathematical modeling of natural resource and human interaction: Applications to the harvesting of Pacific Yew for cancer treatment, 2025, 0, 2155-3289, 0, 10.3934/naco.2025003
  • Reader Comments
  • © 2014 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6215) PDF downloads(987) Cited by(1)

Figures and Tables

Figures(2)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog